中文版 | English
Title

Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer

Author
Corresponding AuthorWu, Zhiqiang
Publication Years
2023-08-01
DOI
Source Title
ISSN
1590-1874
EISSN
1590-3478
Abstract
Posterior reversible encephalopathy syndrome (PRES) is a rare, reversible neurological disease that is frequently associated with the use of targeted therapy agents. In this case study, we examine the development of posterior reversible encephalopathy syndrome (PRES) in a 44-year-old woman with metastatic colon cancer following 1 month of treatment with the vascular endothelial growth factor receptor (VEGFR) inhibitor, fruquintinib. The occurrence of PRES after 1 month of VEGFR inhibitor administration is a common phenomenon. However, it is noteworthy that this is the first reported case of PRES associated with fruquintinib. The patient's neurological function improved upon discontinuing the drug for a week, but worsening was observed following a lower-dose fruquintinib treatment. This patient's experience highlights the potential for neurological deterioration in those treated with fruquintinib, prompting physicians to consider the possibility of PRES. Notably, this may be the first reported case linking fruquintinib to the syndrome, underscoring the importance of recognizing the association between PRES and fruquintinib.
Keywords
URL[Source Record]
Indexed By
Language
English
SUSTech Authorship
Others
WOS Research Area
Neurosciences & Neurology
WOS Subject
Clinical Neurology ; Neurosciences
WOS Accession No
WOS:001049066000002
Publisher
ESI Research Field
NEUROSCIENCE & BEHAVIOR
Data Source
Web of Science
Citation statistics
Document TypeJournal Article
Identifierhttp://kc.sustech.edu.cn/handle/2SGJ60CL/583024
DepartmentShenzhen People's Hospital
Affiliation
1.Wuhan Univ Sci & Technol, Xiaogan Hosp, Dept Neurol, Xiaogan, Hubei, Peoples R China
2.Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp, Affiliated Hosp 1,Dept Neurol,Clin Med Coll 2, Shenzhen 518001, Guangdong, Peoples R China
Recommended Citation
GB/T 7714
Wang, Lu,Zeng, Zhaohao,Wu, Zhiqiang. Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer[J]. NEUROLOGICAL SCIENCES,2023.
APA
Wang, Lu,Zeng, Zhaohao,&Wu, Zhiqiang.(2023).Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer.NEUROLOGICAL SCIENCES.
MLA
Wang, Lu,et al."Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer".NEUROLOGICAL SCIENCES (2023).
Files in This Item:
There are no files associated with this item.
Related Services
Fulltext link
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Export to Excel
Export to Csv
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Wang, Lu]'s Articles
[Zeng, Zhaohao]'s Articles
[Wu, Zhiqiang]'s Articles
Baidu Scholar
Similar articles in Baidu Scholar
[Wang, Lu]'s Articles
[Zeng, Zhaohao]'s Articles
[Wu, Zhiqiang]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wang, Lu]'s Articles
[Zeng, Zhaohao]'s Articles
[Wu, Zhiqiang]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.